Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group
Titel:
Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group
Auteur:
Arnold, D. Höhler, T. Dittrich, C. Lordick, F. Seufferlein, T. Riemann, J. Wöll, E. Herrmann, T. Zubel, A. Schmoll, H.-J.